Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Griffiths

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
International Journal of Antimicrobial Agents|February 9, 2011
Ganciclovir treatment in children: evidence of subtherapeutic levelsSuzanne Luck, Andrew Lovering, Paul Griffiths, et al.
Addiction (Abingdon, England)|August 12, 2021
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?Brendan Hughes, Liesbeth Vandam, Jane Mounteney, et al.
Addiction (Abingdon, England)|February 4, 2017
European observations on cannabis legalizationBrendan Hughes, Eoghan Quigley, Danilo Ballotta, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 13, 2019
Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: The Born in Bradford cohort, UKLucy Pembrey, Dagmar Waiblinger, Paul Griffiths, et al.
The International Journal on Drug Policy|May 16, 2015
Fentanyls: Are we missing the signs? Highly potent and on the rise in EuropeJane Mounteney, Isabelle Giraudon, Gleb Denissov, et al.
Neuroradiology|February 27, 2013
Prospective comparison of late 3T MRI with conventional angiography in evaluating the patency of cerebral arteriovenous malformations treated with stereotactic radiosurgeryNader Khandanpour, Paul Griffiths, Daniel Warren, et al.
Addiction (Abingdon, England)|April 17, 2008
Trends in overdose deaths from drug misuse in Europe: what do the data tell us?Oliver Morgan, Julian Vicente, Paul Griffiths, et al.
Addiction (Abingdon, England)|July 28, 2010
How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case studyPaul Griffiths, Roumen Sedefov, Ana Gallegos, et al.
Advances in Experimental Medicine and Biology|December 2, 2010
Antiviral therapy of CMV disease in childrenMike Sharland, Suzanne Luck, Paul Griffiths, et al.
Drug and Alcohol Review|March 28, 2008
Quite a lot of smoke but very limited fire--the use of methamphetamine in EuropePaul Griffiths, Viktor Mravcik, Dominique Lopez, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
International Journal of Antimicrobial Agents|February 9, 2011
Ganciclovir treatment in children: evidence of subtherapeutic levelsSuzanne Luck, Andrew Lovering, Paul Griffiths, et al.
Addiction (Abingdon, England)|August 12, 2021
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?Brendan Hughes, Liesbeth Vandam, Jane Mounteney, et al.
Addiction (Abingdon, England)|February 4, 2017
European observations on cannabis legalizationBrendan Hughes, Eoghan Quigley, Danilo Ballotta, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 13, 2019
Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: The Born in Bradford cohort, UKLucy Pembrey, Dagmar Waiblinger, Paul Griffiths, et al.
The International Journal on Drug Policy|May 16, 2015
Fentanyls: Are we missing the signs? Highly potent and on the rise in EuropeJane Mounteney, Isabelle Giraudon, Gleb Denissov, et al.
Neuroradiology|February 27, 2013
Prospective comparison of late 3T MRI with conventional angiography in evaluating the patency of cerebral arteriovenous malformations treated with stereotactic radiosurgeryNader Khandanpour, Paul Griffiths, Daniel Warren, et al.
Addiction (Abingdon, England)|April 17, 2008
Trends in overdose deaths from drug misuse in Europe: what do the data tell us?Oliver Morgan, Julian Vicente, Paul Griffiths, et al.
Addiction (Abingdon, England)|July 28, 2010
How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case studyPaul Griffiths, Roumen Sedefov, Ana Gallegos, et al.
Advances in Experimental Medicine and Biology|December 2, 2010
Antiviral therapy of CMV disease in childrenMike Sharland, Suzanne Luck, Paul Griffiths, et al.
Drug and Alcohol Review|March 28, 2008
Quite a lot of smoke but very limited fire--the use of methamphetamine in EuropePaul Griffiths, Viktor Mravcik, Dominique Lopez, et al.
Pageof 19